The Business Research Company’s 2026 market reports feature enhanced tools like market attractiveness analysis, TAM assessment, and company scoring matrices, along with interactive dashboards, deeper supply chain insights, and startup coverage strengthening the depth, usability, and strategic value of insights.
What Is The Projected Increase In Market Value Of The Group B Streptococcus Infection Treatment Market During 2026–2030?
The group b streptococcus infection treatment market size has experienced strong expansion in recent years. This market is set to increase from $1.26 billion in 2025 to $1.36 billion in 2026, progressing at a compound annual growth rate (CAGR) of 8.3%. The growth observed in the past can be attributed to several factors, including rising awareness of neonatal infections, the expansion of prenatal care programs, the widespread use of beta-lactam antibiotics, an increase in hospital-based screening protocols, and the availability of microbiological testing services.
The market for group b streptococcus infection treatment is projected to experience substantial expansion over the coming years. This market is anticipated to reach a valuation of $1.89 billion by 2030, exhibiting a compound annual growth rate (CAGR) of 8.6%. Factors driving this growth during the projected period include the rising development of GBS vaccines, increased uptake of point-of-care diagnostics, a heightened focus on managing antimicrobial resistance, the broadening of molecular testing infrastructure, and a greater emphasis on preventive maternal healthcare. Key trends expected within this forecast timeframe encompass the increasing implementation of rapid molecular diagnostic testing, a greater focus on prenatal GBS screening programs, expanded utilization of antibiotic stewardship protocols, the development of new pipeline therapies for GBS prevention, and improved monitoring of maternal and neonatal outcomes.
Access Your Free Sample Report For In-Depth Market Analysis:
https://www.thebusinessresearchcompany.com/sample.aspx?id=33144&type=smp
Which Strong Drivers Are Impacting The Group B Streptococcus Infection Treatment Market Growth?
The anticipated increase in healthcare spending is expected to propel the growth of the group B streptococcus infection treatment market in the coming years. Healthcare expenditure refers to the total financial resources allocated for medical services, preventive care, medications, infrastructure, and related health initiatives aimed at maintaining or improving public health. This rise in expenditure is driven by the increasing prevalence of chronic and infectious diseases, which, in turn, generates a sustained need for long-term treatment, advanced therapies, and continuous medical attention. Enhanced healthcare expenditure strengthens the group B Streptococcus infection treatment sector by boosting investments in prenatal screening, clinical infrastructure, and vaccine research. These combined efforts lead to improved early detection, prevention, and effective management of GBS infections in mothers and newborns. For instance, in April 2025, the Office for National Statistics, a UK-based government organization, reported that overall healthcare spending rose by 6.5% from 2023 to 2024, indicating an acceleration compared to the 6.3% growth recorded in 2023. Thus, the growing healthcare expenditure is a significant driver for the expansion of the group B streptococcus infection treatment market.
How Is The Group B Streptococcus Infection Treatment Market Categorized Across Its Segment Groups?
The group b streptococcus infection treatment market covered in this report is segmented –
1) By Treatment Type: Antibiotic Therapy; Intravenous Immunoglobulin (IVIG); Experimental Therapies
2) By Drug Class: Beta-Lactam Antibiotic; Clindamycin And Alternatives; Pipeline Therapies
3) By Route of Administration: Oral Administration; Intravenous Administration; Topical Application
4) By Patient Type: Newborns; Pregnant Women; Immunocompromised Patients; Elderly Population
5) By End User: Hospitals; Clinics; Research Institutions; Home Care Settings
Subsegments:
1) By Antibiotic Therapy: Penicillin Based Antibiotics; Cephalosporin Antibiotics; Macrolide Antibiotics; Aminoglycoside Antibiotics
2) By Intravenous Immunoglobulin (IVIG): Standard Polyclonal Immunoglobulin; High Dose Immunoglobulin Therapy; Adjunctive Immunoglobulin Therapy
3) By Experimental Therapies: Vaccine Based Therapies; Monoclonal Antibody Therapies; Bacteriophage Therapies; Immunomodulatory Therapies
Which Trends Are Contributing To Changes In The Group B Streptococcus Infection Treatment Market?
Key companies in the group B streptococcus infection treatment market are concentrating on creating cutting-edge products, including polysaccharide conjugate vaccines, with the goal of decreasing asymptomatic bacterial carriage. These vaccines are a type of immunization where bacterial surface sugars are chemically attached to a carrier protein, boosting immune recognition and producing a robust, enduring protective response, particularly for infants and young children. As an illustration, in September 2023, Omniose, a US-based biotechnology firm, disclosed receiving a grant award of up to $3.0 million from the National Institute of Allergy and Infectious Diseases, part of the U.S. National Institutes of Health, to aid in the creation of a Group B Streptococcus (GBS) vaccine. The distinguishing characteristic of this vaccine is its objective to achieve substantial efficacy via a considerably streamlined manufacturing method. Omniose’s platform utilizes synthetic biology and a single-step enzymatic process within an engineered E. coli cell to create GBS polysaccharide conjugate vaccines, thereby removing traditional chemical conjugation procedures. This method ensures the preservation of 100% of sialic acid residues on each capsular polysaccharide, which has been demonstrated as crucial for eliciting powerful functional antibody responses against particular GBS serotypes.
Which Firms Are Influencing Competition In The Group B Streptococcus Infection Treatment Market?
Major companies operating in the group b streptococcus infection treatment market are Merck & Co. Inc., Pfizer Inc., Sanofi S.A., Novartis AG, GlaxoSmithKline plc, Biological E. Limited, Serum Institute of India Pvt. Ltd., Walvax Biotechnology Co. Ltd., Vaxcyte Inc., Bharat Biotech International Limited, Clover Biopharmaceuticals Ltd., Biovac Institute (Pty) Ltd., Inventprise Inc., BioNet Asia Co. Ltd., GeneOne Life Science Inc., Alopexx Enterprises LLC, Wellstat Vaccines LLC, MinervaX ApS, and ShanghAI Zerun Biotechnology Co. Ltd.
Get The Full Group B Streptococcus Infection Treatment Market Report:
Where Is The Group B Streptococcus Infection Treatment Market Most Concentrated Geographically?
North America was the largest region in the group B streptococcus infection treatment market in 2025. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in the group b streptococcus infection treatment market report are Asia-Pacific, South East Asia, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.
Request A Customized Group B Streptococcus Infection Treatment Market Report For Competitive Insights:
https://www.thebusinessresearchcompany.com/customise?id=33144&type=smp
Browse Through More Reports Similar to the Global Group B Streptococcus Infection Treatment Market 2026, By The Business Research Company
Strep Throat Treatment Market Report 2026
https://www.thebusinessresearchcompany.com/report/strep-throat-treatment-global-market-report
Antibacterial Products Market Report 2026
https://www.thebusinessresearchcompany.com/report/antibacterial-products-global-market-report
Hospital Acquired Infection Control Market Report 2026
Get in touch with us:
The Business Research Company: https://www.thebusinessresearchcompany.com/
Americas +1 310-496-7795
Asia +44 7882 955267 & +91 8897263534
Europe +44 7882 955267
Email us at info@tbrc.info
Follow us on:
LinkedIn: https://in.linkedin.com/company/the-business-research-company
YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ
Global Market Model: https://www.thebusinessresearchcompany.com/global-market-model